Form D — Faeth Therapeutics, Inc.
0002100543-26-000001 · filed Jan 27, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $24,999,993
- Reported amount sold
- $24,434,214
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Faeth Therapeutics, Inc.
- CIK
- 2100543
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 701 TILLERY ST #12 #1010
AUSTIN, TX 78702 - Phone
- 510-858-1839
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Oliver Maddocks · Executive OfficerAustin, TX Find on LinkedIn ↗
-
Anand Parikh · Executive OfficerAustin, TX Find on LinkedIn ↗
-
Jayson Dallas · DirectorAustin, TX Find on LinkedIn ↗
-
Robert Gould · DirectorAustin, TX Find on LinkedIn ↗
-
Alex Morgan · DirectorAustin, TX Find on LinkedIn ↗
-
Stephen Hahn · DirectorAustin, TX Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗